Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
seems that they may use the Shingrix diluent for the Priorix lyoph powder; vaccines where given without the diluent; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in specified number of patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced wrong solution used in drug reconstitution (Verbatim: seems that they may use the Shingrix diluent for the Priorix lyoph powder) and inappropriate dose of vaccine administered (Verbatim: vaccines where given without the diluent). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24-APR-2025 Other HCP reported that they had 2 situation which the diluent was not use to diluent the injection. Reporter stated that they had in the inventory 2 Priorix diluents left alone, so that's why they assume the Priorix vaccines were given without the diluent. Also, indicated that they also had the Shingrix vaccine, so due to this, it seems that they may use the Shingrix diluent for the Priorix lyoph. powder, HCP did not confirmed this. Priorix reconstituted with diluent of Shingrix instead of the supplied liquid conjugate, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.